Back

Efficacy of sodium glucose cotransporter 2 inhibitors for heart failure with preserved and mildly reduced ejection fraction: a systematic review and meta-analysis

1 December 2022 (08:00 - 19:00)
Organised by:
Congress Presentation Part of: Poster Session 1 Treatment ESC Professional Premium Access ESC Asia 2022 with APSC & AFC

About the speaker

Photo
Doctor Kathleen Rivera

Philippine Heart Center, Manila (Philippines)

27 More presentations in this session

Presentation thumbnail
Frequent need for apixaban dose adjustment for atrial fibrillation in an unselected acute medical admission population during the COVID 19 pandemic.
Doctor K. Kyaw (Plymouth, GB)
Abstract Slides
Presentation thumbnail
The use of hatch score for the prediction of post operative atrial fibrillation (poaf) after coronary artery bypass graft: a meta-analysis
Doctor A. Ramos (Muntinlupa, PH)
Abstract Slides
Presentation thumbnail
Relationship and outcomes between volume status, cardiac and renal dysfunction in patients with chronic heart failure.
Doctor A. Challa (Rochester, US)
Abstract Slides
Presentation thumbnail
Association between triglyceride and all-cause mortality and cardiovascular outcomes in heart failure patients: a territory-wide study in Hong Kong
Mrs Q. Ren (Hong Kong, HK)
Abstract Slides
Presentation thumbnail
Effects of SGLT2 inhibitors on heart failure symptoms, quality of life and exercise capacity in patients with heart failure and preserved ejection fraction: A meta-analysis
Doctor L. Merin (Cebu City, PH)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1

The Event

Event poster

ESC Asia 2022 with APSC & AFC

1 December - 3 December 2022
You may be interested in
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
Expert panel discussion and Q&A

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources